13-Valent Pneumococcal Conjugate Vaccine(Antekin)

13价肺炎球菌结合疫苗（安特金）

Report date: 2022/05/09 20:00:49

Base Information

Drug Name13-Valent Pneumococcal Conjugate Vaccine(Antekin)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 3 Clinical

Originator CompaniesFosun Adgenvax Biopharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesFosun Adgenvax Biopharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsPneumococcal Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A